These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 28872973)

  • 1. Splenectomy-Induced Leukocytosis Promotes Intratumoral Accumulation of Myeloid-Derived Suppressor Cells, Angiogenesis and Metastasis.
    Sevmis M; Yoyen-Ermis D; Aydin C; Bilgic E; Korkusuz P; Uner A; Hamaloglu E; Esendagli G; Karakoc D
    Immunol Invest; 2017 Oct; 46(7):663-676. PubMed ID: 28872973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophages are more potent immune suppressors ex vivo than immature myeloid-derived suppressor cells induced by metastatic murine mammary carcinomas.
    Hamilton MJ; Bosiljcic M; Lepard NE; Halvorsen EC; Ho VW; Banáth JP; Krystal G; Bennewith KL
    J Immunol; 2014 Jan; 192(1):512-22. PubMed ID: 24285836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCL17-derived CD11b
    Hsu YL; Yen MC; Chang WA; Tsai PH; Pan YC; Liao SH; Kuo PL
    Breast Cancer Res; 2019 Feb; 21(1):23. PubMed ID: 30755260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells.
    Jovanovic IP; Pejnovic NN; Radosavljevic GD; Pantic JM; Milovanovic MZ; Arsenijevic NN; Lukic ML
    Int J Cancer; 2014 Apr; 134(7):1669-82. PubMed ID: 24105680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single Cell Mass Cytometry Revealed the Immunomodulatory Effect of Cisplatin Via Downregulation of Splenic CD44+, IL-17A+ MDSCs and Promotion of Circulating IFN-γ+ Myeloid Cells in the 4T1 Metastatic Breast Cancer Model.
    Balog JÁ; Hackler L; Kovács AK; Neuperger P; Alföldi R; Nagy LI; Puskás LG; Szebeni GJ
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31881770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting myeloid-derived suppressor cells in combination with primary mammary tumor resection reduces metastatic growth in the lungs.
    Bosiljcic M; Cederberg RA; Hamilton MJ; LePard NE; Harbourne BT; Collier JL; Halvorsen EC; Shi R; Franks SE; Kim AY; Banáth JP; Hamer M; Rossi FM; Bennewith KL
    Breast Cancer Res; 2019 Sep; 21(1):103. PubMed ID: 31488209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visualization and quantification of
    Hoffmann SHL; Reck DI; Maurer A; Fehrenbacher B; Sceneay JE; Poxleitner M; Öz HH; Ehrlichmann W; Reischl G; Fuchs K; Schaller M; Hartl D; Kneilling M; Möller A; Pichler BJ; Griessinger CM
    Theranostics; 2019; 9(20):5869-5885. PubMed ID: 31534525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function.
    Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS
    J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splenectomy suppresses growth and metastasis of hepatocellular carcinoma through decreasing myeloid-derived suppressor cells in vivo.
    Long X; Wang J; Zhao JP; Liang HF; Zhu P; Cheng Q; Chen Q; Wu YH; Zhang ZG; Zhang BX; Chen XP
    J Huazhong Univ Sci Technolog Med Sci; 2016 Oct; 36(5):667-676. PubMed ID: 27752888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioprotective Role of Myeloid-Derived Suppressor Cells in Heart Failure.
    Zhou L; Miao K; Yin B; Li H; Fan J; Zhu Y; Ba H; Zhang Z; Chen F; Wang J; Zhao C; Li Z; Wang DW
    Circulation; 2018 Jul; 138(2):181-197. PubMed ID: 29437117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor- and organ-dependent infiltration by myeloid-derived suppressor cells.
    Younos I; Donkor M; Hoke T; Dafferner A; Samson H; Westphal S; Talmadge J
    Int Immunopharmacol; 2011 Jul; 11(7):816-26. PubMed ID: 21376153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating myeloid-derived suppressor cells: An independent prognostic factor in patients with breast cancer.
    Safarzadeh E; Hashemzadeh S; Duijf PHG; Mansoori B; Khaze V; Mohammadi A; Kazemi T; Yousefi M; Asadi M; Mohammadi H; Babaie F; Baradaran B
    J Cell Physiol; 2019 Apr; 234(4):3515-3525. PubMed ID: 30362521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mutual activation loop between breast cancer cells and myeloid-derived suppressor cells facilitates spontaneous metastasis through IL-6 trans-signaling in a murine model.
    Oh K; Lee OY; Shon SY; Nam O; Ryu PM; Seo MW; Lee DS
    Breast Cancer Res; 2013; 15(5):R79. PubMed ID: 24021059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xuanhusuo powder has an anti-breast cancer effect by inhibiting myeloid-derived suppressor cell differentiation in the spleen of mice through down-regulating granulocyte colony stimulating factor.
    Mao Y; Liu X; He K; Lin C; He B; Gao J
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Feb; 52(1):88-100. PubMed ID: 37283122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocytic myeloid-derived suppressor cells maintain feto-maternal tolerance by inducing Foxp3 expression in CD4+CD25-T cells by activation of the TGF-β/β-catenin pathway.
    Kang X; Zhang X; Liu Z; Xu H; Wang T; He L; Zhao A
    Mol Hum Reprod; 2016 Jul; 22(7):499-511. PubMed ID: 27016139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Circulating Myeloid Suppressor Cells and Their Role in Tumour Immunology].
    Pilatova K; Budinská E; Bensciková B; Nenutil R; Šefr R; Fedorová L; Hanáková B; Brychtová V; Zdražilová Dubská L
    Klin Onkol; 2017; 30(Supplementum1):166-169. PubMed ID: 28471197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of myeloid-derived suppressor cells on angiogenesis and tumor growth after cancer surgery.
    Wang J; Su X; Yang L; Qiao F; Fang Y; Yu L; Yang Q; Wang Y; Yin Y; Chen R; Hong Z
    Int J Cancer; 2016 Jun; 138(11):2688-99. PubMed ID: 26756887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomic profiling of tumor-infiltrating macrophages during tumor growth.
    Umemura N; Sugimoto M; Kitoh Y; Saio M; Sakagami H
    Cancer Immunol Immunother; 2020 Nov; 69(11):2357-2369. PubMed ID: 32518979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical activity delays accumulation of immunosuppressive myeloid-derived suppressor cells.
    Garritson J; Krynski L; Haverbeck L; Haughian JM; Pullen NA; Hayward R
    PLoS One; 2020; 15(6):e0234548. PubMed ID: 32542046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer.
    Yu J; Du W; Yan F; Wang Y; Li H; Cao S; Yu W; Shen C; Liu J; Ren X
    J Immunol; 2013 Apr; 190(7):3783-97. PubMed ID: 23440412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.